4.7 Article

Disease burden of bloodstream infections caused by antimicrobial-resistant bacteria: A population-level study, Japan, 2015-2018

期刊

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
卷 108, 期 -, 页码 119-124

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2021.05.018

关键词

Antimicrobial resistance; Bloodstream infection; DALYs

资金

  1. Ministry of Health, Labour and Welfare Research Grant [20HA2003]
  2. Japan Agency for Medical Research and Development Research Program on Emerging and Re-emerging Infectious Diseases [JP19fk0108061]

向作者/读者索取更多资源

This study estimated the disease burden of bloodstream infections caused by major antimicrobial-resistant bacteria in Japan from 2015 to 2018. The burden associated with AMR in Japan is substantial and has not decreased, with FQREC and 3GREC showing steady increases, while MRSA burden in Japan is larger than in the European Union/European Economic Area. These findings are expected to provide valuable information for healthcare policy makers to prioritize interventions for AMR.
Background: Antimicrobial resistance (AMR) is a global health problem. However, quantitative evaluation of its disease burden is challenging. This study aimed to estimate the disease burden of bloodstream infections (BSIs) caused by major antimicrobial-resistant bacteria in Japan between 2015 and 2018 in terms of disability-adjusted life-years (DALYs). Methods: DALYs of BSIs caused by nine major antimicrobial-resistant bacteria in Japan were estimated using comprehensive national surveillance data of all routine bacteriological test results from more than 1400 hospitals between 2015 and 2018. The methodology of Cassini et al. was modified to enable comparison of the present results with those in other countries. Results: It was estimated that 137.9 [95% uncertainty interval (UI) 130.7-145.2] DALYs per 100,000 population were attributable to BSIs caused by nine antimicrobial-resistant bacteria in 2018. Methicillinresistant Staphylococcus aureus (MRSA), fluoroquinolone-resistant Escherichia coli (FQREC) and third generation cephalosporin-resistant E. coli (3GREC) accounted for 87.2% overall. The burden did not decrease during the study period and was highest in people aged >65 years. Conclusion: The results revealed, for the first time, the disease burden of BSIs caused by nine major antimicrobial-resistant bacteria in Japan. The estimated disease burden associated with AMR in Japan is substantial and has not begun to decrease. Notably, the burden from FQREC and 3GREC has increased steadily, and that from MRSA is larger in Japan than in the European Union/European Economic Area, whereas the burden from other bacteria is comparatively small. These results are expected to provide useful information for healthcare policy makers for prioritizing interventions for AMR. (c) 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-ncnd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods

Kensuke Shoji, Shinya Tsuzuki, Takayuki Akiyama, Nobuaki Matsunaga, Yusuke Asai, Setsuko Suzuki, Noriko Iwamoto, Takanori Funaki, Masaki Yamada, Nobuaki Ozawa, Koushi Yamaguchi, Isao Miyairi, Norio Ohmagari

Summary: This retrospective observational study examined the clinical characteristics and outcomes of pregnant women with COVID-19 in Japan, revealing differences in the effects of the Delta and Omicron variants. The study also identified that onset during the later stage of pregnancy and during the Delta variant period were independently associated with moderate-to-severe COVID-19, while receiving two doses of the SARS-CoV-2 vaccine was protective against developing moderate-to-severe COVID-19.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2023)

Article Infectious Diseases

Temporal trends in microbial detection during the COVID-19 pandemic: Analysis of the Japan surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) database

Akira Endo, Yusuke Asai, Taichi Tajima, Mio Endo, Takayuki Akiyama, Nobuaki Matsunaga, Haruhiko Ishioka, Shinya Tsuzuki, Norio Ohmagari

Summary: The impact of the COVID-19 pandemic on microbial infections and antimicrobial resistance (AMR) has not been fully described. This study used data from the Japan Surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) to assess changes in AMR-related metrics before and after the start of the pandemic. The study found a decrease in microbial infections in 2020, driven by reduced bed occupancy, but the incidence remained constant or slightly increased after adjusting for bed occupancy. The incidence of Streptococcus pneumoniae decreased significantly from April 2020, likely due to non-pharmaceutical interventions against COVID-19. Antimicrobial use showed a weak increasing trend, while hand sanitizer use in medical institutions increased by about 50% in 2020 compared to 2019.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2023)

Article Public, Environmental & Occupational Health

Regional trends in the use of steroids and favipiravir for COVID-19 treatment

Yusuke Asai, Shinya Tsuzuki, Nobuaki Matsunaga, Norio Ohmagari

Summary: This study analyzed the treatment trends of COVID-19 and found regional differences in the use of steroids and favipiravir. The proportion of steroid use increased nationwide, while the use of favipiravir showed a decreasing trend. Registry studies play an important role in the real-time monitoring of medication status and trend analysis.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2023)

Article Immunology

Statistical Analysis of Mortality Rates of Coronavirus Disease 2019 (COVID-19) Patients in Japan Across the 4C Mortality Score Risk Groups, Age Groups, and Epidemiological Waves: A Report From the Nationwide COVID-19 Cohort

Hiroaki Baba, Saori Ikumi, Shotaro Aoyama, Tetsuo Ishikawa, Yusuke Asai, Nobuaki Matsunaga, Norio Ohmagari, Hajime Kanamori, Koichi Tokuda, Takuya Ueda, Eiryo Kawakami

Summary: This study investigated the differences in mortality rates of COVID-19 patients in Japan across 6 epidemiological waves, stratified by age group and 4C mortality score risk group. The results showed that the mortality rates of Japanese patients were significantly lower than those reported in the UK, except for patients aged >= 90 years at very high risk. In the fourth and fifth wave periods, there were no significant differences in mortality rates of patients aged >= 75 years at very high risk compared to the UK, while in the sixth wave period, the mortality rates were significantly lower in all age groups and risk groups.

OPEN FORUM INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2

Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Yusuke Oshiro, Natsumi Inamura, Tetsuya Mizoue, Maki Konishi, Junko S. Takeuchi, Kumi Horii, Mitsuru Ozeki, Haruhito Sugiyama, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari

Summary: Longitudinal data comparing booster effects of Delta breakthrough infection and third vaccine dose on neutralizing antibodies against Omicron are lacking. The study found that Delta breakthrough infection led to significant increases in neutralizing antibody levels against Wild-type and Delta, and 64% of cases developed detectable neutralizing antibodies against Omicron BA.1. However, the neutralizing antibody levels against Omicron were lower compared to Wild-type and Delta. Therefore, infection prevention measures should be continued regardless of vaccine and infection history.

BMC INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Effectiveness of oral cephalexin in antibiotic-course completion for methicillin-susceptible Staphylococcus aureus-induced bacteremic vertebral osteomyelitis

Nobumasa Okumura, Kayoko Hayakawa, Kei Yamamoto, Gen Yamada, Kazuhisa Mezaki, Norio Ohmagari

Summary: This study evaluated the treatment efficacy of cephalexin as oral antibiotic therapy for methicillin-susceptible Staphylococcus aureus (MSSA)-induced pyogenic vertebral osteomyelitis (PVO). The results showed that completion of antibiotic treatment with cephalexin is a reasonable option for patients with MSSA bacteremia and PVO, even in cases with spinal abscess, if effective intravenous antimicrobial therapy is provided for at least 3 weeks.

BMC INFECTIOUS DISEASES (2023)

Article Public, Environmental & Occupational Health

Comparison of risk factors for SARS-CoV-2 infection among healthcare workers during Omicron and Delta dominance periods in Japan

Y. Li, S. Yamamoto, Y. Oshiro, N. Inamura, T. Nemoto, K. Horii, J. S. Takeuchi, T. Mizoue, M. Konishi, M. Ozeki, H. Sugiyama, W. Sugiura, N. Ohmagari

Summary: This study compared the risk factors for SARS-CoV-2 infection among healthcare workers during the Delta and Omicron periods. The risk of infection was 3.4-fold higher during the early Omicron-predominant period compared to the Delta period. Working in a COVID-19-related department or having a higher occupational exposure to SARS-CoV-2 was not significantly associated with an increased infection risk during both periods. However, during the Omicron-predominant period, spending more than 30 minutes in closed spaces, crowded spaces, and close-contact settings without wearing a mask was associated with a higher infection risk.

JOURNAL OF HOSPITAL INFECTION (2023)

Article Hematology

The safety of plasma apheresis from donors recovering from COVID-19 infection in Japan

Ayumi Kamo-Imai, Tomiteru Togano, Motohiko Sato, Yuiko Kawakami, Kumi Inaba, Hiroshi Shimazu, Saori Igarashi, Keiko Tanaka, Mari Terada, Noriko Kinoshita-Iwamoto, Sho Saito, Satoshi Kutsuna, Akira Hangaishi, Shinichiro Morioka, Kenzo Takahashi, Satoshi Miyata, Norio Ohmagari

Summary: This study retrospectively observed the safety of COVID-19 convalescent plasma (CCP) apheresis in Japan. Adverse events occurred during CCP collection, including syncope, hypotension, and nausea. First-time donors and patients with severe illness were more likely to experience adverse events. Despite more adverse events compared to healthy donors, this study confirms the safety of CCP apheresis.

TRANSFUSION AND APHERESIS SCIENCE (2023)

Article Virology

Serum Lactate Dehydrogenase Level One Week after Admission Is the Strongest Predictor of Prognosis of COVID-19: A Large Observational Study Using the COVID-19 Registry Japan

Sho Nakakubo, Yoko Unoki, Koji Kitajima, Mari Terada, Hiroyuki Gatanaga, Norio Ohmagari, Isao Yokota, Satoshi Konno

Summary: This study demonstrates that the lactate dehydrogenase (LDH) level on day 8 is a reliable indicator for predicting in-hospital mortality in COVID-19 patients, suggesting its potential usefulness in post-treatment decision-making in severe cases.

VIRUSES-BASEL (2023)

Article Multidisciplinary Sciences

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

Ryuta Uraki, Shun Iida, Peter J. Halfmann, Seiya Yamayoshi, Yuichiro Hirata, Kiyoko Iwatsuki-Horimoto, Maki Kiso, Mutsumi Ito, Yuri Furusawa, Hiroshi Ueki, Yuko Sakai-Tagawa, Makoto Kuroda, Tadashi Maemura, Taksoo Kim, Sohtaro Mine, Noriko Iwamoto, Rong Li, Yanan Liu, Deanna Larson, Shuetsu Fukushi, Shinji Watanabe, Ken Maeda, Zhongde Wang, Norio Ohmagari, James Theiler, Will Fischer, Bette Korber, Masaki Imai, Tadaki Suzuki, Yoshihiro Kawaoka

Summary: The Omicron subvariant BA.2.75 rapidly spread globally in India and Nepal during the summer of 2022. However, its virological features were largely unknown. In this study, BA.2.75 clinical isolates were evaluated in Syrian hamsters, and it was found that BA.2.75 had higher replicative ability in the lungs compared to BA.2 and BA.5. BA.2.75 also caused focal viral pneumonia in hamsters, unlike BA.5. These findings suggest that BA.2.75 may cause more severe respiratory disease and should be closely monitored.

NATURE COMMUNICATIONS (2023)

Article Tropical Medicine

Imported severe Plasmodium falciparum infection in the first trimester of pregnancy complicated by post-artemisinin delayed hemolysis and intrauterine fetal death, a case report

Kohei Kamegai, Kayoko Hayakawa, Kei Yamamoto, Hidetoshi Nomoto, Kanako Komaki-Yasuda, Shigeyuki Kano, Norio Ohmagari

Summary: This article reports a severe case of Plasmodium falciparum malaria in a pregnant Japanese woman, who developed prolonged anemia and miscarriage after receiving treatment with intravenous quinine and oral artemether-lumefantrine. The authors emphasize the importance of monitoring hemoglobin levels for at least a month in patients who recover from severe malaria after ACT treatment.

TROPICAL MEDICINE AND HEALTH (2023)

Article Public, Environmental & Occupational Health

Association between SARS-CoV-2 anti-spike antibody titers and the development of post-COVID conditions: A retrospective observational

Yusuke Miyazato, Shinya Tsuzuki, Akihiro Matsunaga, Shinichiro Morioka, Mari Terada, Sho Saito, Noriko Iwamoto, Satoshi Kutsuna, Yukihito Ishizaka, Norio Ohmagari

Summary: Post-COVID conditions refer to the symptoms that persist after acute COVID-19, and the effect of serum antibody titers against SARS-CoV-2 on their development was investigated. A retrospective study of COVID-19-recovered individuals was conducted, and serum antibody titers and demographic information were collected. Participants were divided into two groups based on antibody titers, and the frequency of post-COVID conditions was compared. The incidence of depressed mood was significantly higher in the group with higher antibody titers, indicating a difference in pathogenesis that requires further investigation.

GLOBAL HEALTH & MEDICINE (2023)

Article Infectious Diseases

Factors Associated with Geographical Variability of Antimicrobial Use in Japan

Taito Kitano, Shinya Tsuzuki, Ryuji Koizumi, Kensuke Aoyagi, Yusuke Asai, Yoshiki Kusama, Norio Ohmagari

Summary: This study analyzes data from the 47 prefectures of Japan and finds that the geographical variation of antimicrobial use (AMU) is associated with the proportion of female individuals, education level, and the number of diagnoses related to upper respiratory infections.

INFECTIOUS DISEASES AND THERAPY (2023)

Article Pediatrics

Comparing the effects of antimicrobial stewardship at primary emergency centers

Shogo Otake, Yoshiki Kusama, Shinya Tsuzuki, Shota Myojin, Makoto Kimura, Naohiro Kamiyoshi, Toru Takumi, Akihito Ishida, Masashi Kasai

Summary: The study found that a facility-specific guideline was less effective than a nudge-based antimicrobial stewardship program in reducing oral third-generation cephalosporin prescriptions in Primary Emergency Medical Centers (PECs).

PEDIATRICS INTERNATIONAL (2023)

Article Obstetrics & Gynecology

Does the experience of the first assistant affect organ injuries in laparoscopic hysterectomy for benign diseases?

Yoko Tsuzuki, Takumi Hirata, Shinya Tsuzuki, Shinichiro Wada, Akiko Tamakoshi

Summary: This study aimed to investigate whether the experience level of the first assistant surgeon affects perioperative organ injuries in patients undergoing TLH for benign diseases. The results showed that the inclusion of a less experienced first assistant, when there is an experienced primary surgeon, does not negatively impact the occurrence of perioperative organ injuries.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2023)

暂无数据